S-1/docetaxel compared with the other standard S-1 based regimens as a first-line chemotherapy for patients with advanced gastric cancer.
Tetsuya Kusumoto
No relevant relationships to disclose
Koji Ando
No relevant relationships to disclose
Satoshi Ida
No relevant relationships to disclose
Yasue Kimura
No relevant relationships to disclose
Hiroshi Saeki
No relevant relationships to disclose
Eiji Oki
No relevant relationships to disclose
Masaru Morita
No relevant relationships to disclose
Yoshihiko Maehara
No relevant relationships to disclose